Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Express Scripts
Colorcon
Mallinckrodt
McKinsey

Last Updated: October 19, 2019

DrugPatentWatch Database Preview

Seattle Genetics Company Profile

See Plans and Pricing

« Back to Dashboard

Summary for Seattle Genetics
Patents:34
Tradenames:1
Ingredients:1
BLAs:2

US Patents for Seattle Genetics

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Seattle Genetics ADCETRIS brentuximab vedotin INJECTABLE; INJECTION 125399 001 2011-08-19 9,952,300 BRACCO IMAGING S.P.A. (Milan, IT) 2032-03-05 RX search
Seattle Genetics ADCETRIS brentuximab vedotin INJECTABLE; INJECTION 125399 001 2011-08-19 9,931,458 ADIENNE PHARMA & BIOTECH SA (Lugano, CH) 2037-05-31 RX search
Seattle Genetics ADCETRIS brentuximab vedotin INJECTABLE; INJECTION 125399 001 2011-08-19 9,931,359 The Johns Hopkins University (Baltimore, MD) 2030-05-26 RX search
Seattle Genetics ADCETRIS brentuximab vedotin INJECTABLE; INJECTION 125399 001 2011-08-19 9,926,324 CALITOR SCIENCES, LLC (Newbury Park, CA) SUNSHINE LAKE PHARMA CO., LTD. (Dongguan, Guangdong, CN) 2032-11-14 RX search
Seattle Genetics ADCETRIS brentuximab vedotin INJECTABLE; INJECTION 125399 001 2011-08-19 9,890,136 THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK MEMORIAL SLOAN-KETTERING CANCER CENTER (New York, NY) 2034-12-23 RX search
Seattle Genetics ADCETRIS brentuximab vedotin INJECTABLE; INJECTION 125399 001 2011-08-19 9,849,193 University of Louisville Research Foundation, Inc. (Louisville, KY) 2033-02-08 RX search
Seattle Genetics ADCETRIS brentuximab vedotin INJECTABLE; INJECTION 125399 001 2011-08-19 9,844,582 Massachusetts Institute of Technology (Cambridge, MA) 2032-05-22 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
Harvard Business School
McKesson
Baxter
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.